shortagewatch

Home / Cancer and immune system / Cytarabine

ATC L01BC01 · Antineoplastic Agents

Cytarabine shortage

As of 31 Oct 2026, Cytarabine has a reported shortage in 3 of the 5 countries we track (Germany, Italy, Spain), covering 13 products.

Countries3/5
Products13packs or presentations
Short since16 Apr 20233.5 years ago
Earliest return29 Nov 2026company estimate
No return date6products
Main reasonNot stated
Germany5 packs shortItaly2 packs shortSpain6 packs shortAustriaNo reported shortageBelgiumNo reported shortage

Timeline

GermanyItalySpain
2024202520262028ARA-cell 1000mg InfusionslösungARA-cell 1000mg InfusionslösungARA-cell 4000mg InfusionslösungARA-cell 4000mg InfusionslösungARA-cell 100 mg/ml Konzentrat zur HerstellunARA-cell 100 mg/ml Konzentrat zur Herstellung einer InfusionslösungARA-cell 100 mg/ml Konzentrat zur HerstellunARA-cell 100 mg/ml Konzentrat zur Herstellung einer InfusionslösungARA-cell 40mg InjektionARA-cell 40mg InjektionCITARABINA ACCORDCITARABINA ACCORDCITARABINA ACCORDCITARABINA ACCORDCITARABINA PFIZER 100 mg POLVO Y DISOLVENTE CITARABINA PFIZER 100 mg POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 1 vial + 1 ampolla de disolventeCITARABINA PFIZER 100 mg POLVO Y DISOLVENTE CITARABINA PFIZER 100 mg POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 100 viales + 100 ampollas de disolventeCITARABINA ACCORD 100 mg/ml SOLUCION INYECTACITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 1 mlCITARABINA PFIZER 20 MG/ML SOLUCION INYECTABCITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 25 mlCITARABINA ACCORD 100 mg/ml SOLUCION INYECTACITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 5 mlCITARABINA ACCORD 100 mg/ml SOLUCION INYECTACITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 20 mltoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
DEARA-cell 1000mg InfusionslösungSTADAPHARM GmbH7 Oct 202531 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEARA-cell 4000mg InfusionslösungSTADAPHARM GmbH14 Mar 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEARA-cell 100 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH4 May 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEARA-cell 100 mg/ml Konzentrat zur Herstellung einer InfusionslösungSTADAPHARM GmbH4 May 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
DEARA-cell 40mg InjektionSTADAPHARM GmbH2 Sep 202631 Dec 2027Manufacturing problem
Probleme in der Herstellung
ITCITARABINA ACCORDACCORD HEALTHCARE, S.L.U.1 Oct 2026not givenCommercial decision or withdrawal
Motivi commerciali
ITCITARABINA ACCORDACCORD HEALTHCARE, S.L.U.1 Oct 2026not givenCommercial decision or withdrawal
Motivi commerciali
ESCITARABINA PFIZER 100 mg POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 1 vial + 1 ampolla de disolventePfizer S.L.16 Apr 2023not givenNot stated
ESCITARABINA PFIZER 100 mg POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN , 100 viales + 100 ampollas de disolventePfizer S.L.18 Feb 2024not givenNot stated
ESCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 1 mlAccord Healthcare S.L.U.1 Jun 202528 Jan 2027Not stated
ESCITARABINA PFIZER 20 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION, 1 vial de 25 mlPfizer S.L.6 Aug 2025not givenNot stated
ESCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 5 mlAccord Healthcare S.L.U.25 May 202629 Nov 2026Not stated
ESCITARABINA ACCORD 100 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION , 1 vial de 20 mlAccord Healthcare S.L.U.28 Sep 2026not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Related medicines also in short supply

Azacitidine Capecitabine Fluorouracil Gemcitabine Trifluridine, Combinations